If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: NewsMaker
Press Release: AIMM : Global Hepatitis C - Pipeline Review, H2 2016
The report provides comprehensive information on the therapeutics under development for Chronic Hepatitis C complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type....
Read full article »
AIMM's Competitors
|
AIMM's News
|
AIMM's Financials
Follow
Followers on Owler
1
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO
Update CEO
CEO Approval Rating
- -/100
Read more
See Aimmtherapeutics company profile »
